首页LSTA • NASDAQ
add
Lisata Therapeutics Inc
昨日收盘价
$2.77
当日价格范围
$2.65 - $2.82
年度波幅
$1.87 - $4.20
市值
2368.66万 USD
平均交易量
5.12万
市盈率
-
股息率
-
主要交易所
NASDAQ
财务信息
损益表
收入
净收入
| (USD) | 2025年6月info | 年同比变化 |
|---|---|---|
收入 | 7.00万 | — |
经营支出 | 493.80万 | -10.59% |
净收入 | -465.90万 | 7.63% |
净利润率 | -6655.71 | — |
每股收益 | -0.54 | 11.48% |
息税折旧摊销前利润 | -482.40万 | 11.94% |
有效税率 | — | — |
资产负债表
总资产
负债总额
| (USD) | 2025年6月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 2197.00万 | -42.58% |
总资产 | 2516.00万 | -40.90% |
负债总额 | 438.50万 | -4.17% |
权益总额 | 2077.50万 | — |
发行在外的股份 | 875.59万 | — |
市净率 | 1.14 | — |
资产回报率 | -44.96% | — |
资本回报率 | -52.95% | — |
现金流
现金净变动
| (USD) | 2025年6月info | 年同比变化 |
|---|---|---|
净收入 | -465.90万 | 7.63% |
来自运营的现金 | -395.60万 | 25.12% |
投资现金 | 50.50万 | -95.69% |
融资现金 | 6.40万 | 100.00% |
现金净变动 | -338.20万 | -152.13% |
自由现金流 | -253.15万 | 28.81% |
简介
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
成立时间
1980
员工数量
26
